Description
Tesofensine is an investigational compound that has been studied for its potential in the treatment of obesity. It belongs to the class of serotonin-norepinephrine-dopamine reuptake inhibitors (SNDRI) and is thought to work by increasing levels of neurotransmitters that play a role in appetite regulation and energy expenditure. Tesofensine was initially developed as an antidepressant but gained attention due to its observed weight loss effects during clinical trials.
Reviews
There are no reviews yet.